LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020)
LifeMD posted quarterly Asset Writedowns and Impairment of $74530.0 for Q4 2020, up 1728.72% on a QoQ basis from -$4576.0 in Q3 2017.
LifeMD (LFMD) has 3 years of Asset Writedowns and Impairment data on file, last reported at $74530.0 in Q4 2020.
- For the quarter ending Q4 2020, Asset Writedowns and Impairment changed N/A year-over-year to $74530.0; the trailing twelve-month figure through Dec 2021 stood at $74530.0 (up 17.48% YoY), and the FY2024 full-year result was $675669.0, up 25.66% from the prior year.
- Asset Writedowns and Impairment for Q4 2020 stood at $74530.0, up from -$4576.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $114694.0 in Q4 2016 and bottomed at -$38027.0 in Q1 2017.
- The 3-year median for Asset Writedowns and Impairment is -$4576.0 (2017), against an average of $28021.0.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | LifeMD | 219.40 Mn | 219.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 74,530.00 |
| Dec 31, 2020 | 74,530.00 |
| Sep 30, 2017 | -4,576.00 |
| Sep 30, 2017 | -4,576.00 |
| Jun 30, 2017 | -6,516.00 |
| Jun 30, 2017 | -6,516.00 |
| Mar 31, 2017 | -38,027.00 |
| Mar 31, 2017 | -38,027.00 |
| Dec 31, 2016 | 114,694.00 |
| Dec 31, 2016 | 114,694.00 |